Aura Biosciences AURA
NASDAQ AURA
$7.61 -0.04 (-0.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Aura Biosciences (AURA) Other Non-Current Liabilities (2020 - 2022)

Updated

Aura Biosciences' Other Non-Current Liabilities came in at $67,000 for Q2 2022, down 47.2% from the prior quarter.

Analysis

Aura Biosciences (AURA) Other Non-Current Liabilities (2020 - 2022) Analysis & Trends

At the end of FY2021, Aura Biosciences' Other Non-Current Liabilities was $83,000, up 15.3% from FY2020.

  • Going back by year, Other Non-Current Liabilities was $72,000 in FY2020.
  • Business Quant data shows AURA's Other Non-Current Liabilities at $127,000 (Q1 2022), $83,000 (Q4 2021) and $71,000 (Q3 2021) in the three quarters before Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Aura Biosciences 796.17 Mn 542.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 67,000.00
Mar 31, 2022 127,000.00
Dec 31, 2021 83,000.00
Sep 30, 2021 71,000.00
Dec 31, 2020 80,000.00
API Access

Aura Biosciences Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AURA&period=max&api_key=YOUR_API_KEY